Frequently asked questions

Start with the problem you want assessed, not the label in an advertisement. Ask the provider for the professional's name, current licence, clinical specialty and relevant experience. Confirm whether the appointment covers sexual function, infection testing, pain or relationship support, and whether another specialty may be needed. A search term such as sexologist does not, by itself, verify a person's qualifications or confirm an appointment through this guide.

Yes. Concerns involving desire, arousal, erection, orgasm, ejaculation or pain are common and can change across life stages.

Yes. Some prescription medicines and substances can contribute. Do not stop prescribed treatment yourself; ask the prescriber to review options.

The current US-approved bremelanotide product is a subcutaneous injection for a specific indication in premenopausal women, not a nasal spray.

Sometimes a conversation is enough to plan the next step, but certain symptoms require a physical examination or targeted tests. The clinician should explain why and obtain consent.

Yes. Desire varies with age, health, medicines, sleep, stress, life events and relationship context. A change only needs assessment if it persists and causes you distress, or if it began alongside a new medicine or diagnosis.

No. Many sexually transmitted infections cause no symptoms for a period, which is why screening is based on exposure and recommended intervals rather than on how you feel.

Often, yes. Cardiovascular conditions, diabetes, hormonal changes, pelvic pain, mood disorders, sleep problems and a number of prescription medicines can all contribute.

Licensing in Dubai is handled by the Dubai Health Authority, and both facilities and individual clinicians hold licences. Ask for the licence details and confirm the specialty matches the care being offered.

This site does not collect clinical information or provide consultations. Anything you send through a contact link goes to an external licensed provider, whose own privacy terms apply.

Long enough for a full history, which is normally longer than a routine appointment. If examination or testing is needed, it may be arranged in the same visit or booked separately depending on the service.

Not always. Many concerns can be assessed by history alone at first. Where an examination is needed it should be explained beforehand, done with your consent, and stopped at any point if you ask.

No. These questions are asked because relationship context frequently contributes, but you can decline any question and still be assessed.

Usually yes, and for some concerns it helps. You should also be offered part of the appointment alone, since some information is easier to give privately.

Normal results are informative — they exclude specific causes. Many sexual-health concerns have contributors that no test measures, and the assessment continues from there rather than stopping.

No. Sexual-health concerns have different causes, and a treatment that suits one cause will do nothing for another. Any protocol presented as universally suitable should prompt a question about what assessment it was based on.

Sometimes a clinician will start a reasonable first step while investigation continues, but this should be a stated decision with a review point — not a substitute for assessment.

It depends on the concern. Where a relationship or communication component is prominent, involving a partner frequently improves the outcome. Where an infection is confirmed, partner notification is usually part of treatment.

Often not. Formulation, dose, purity and regulatory oversight can all differ from the approved product, and a product bought without assessment has not been checked against your own contraindications.

That is a normal step rather than a dead end. It narrows the likely cause, and the next option should already have been discussed when the first one was agreed.

The review point should be set before you start, because it differs by treatment. What matters is that it is a specific date rather than an open-ended instruction to continue and see.

Not necessarily — many ease within the first weeks. They are a reason to report, so the clinician can judge whether to continue, adjust the dose or change approach.

Report it before the scheduled review. A symptom that returns after a clear improvement is useful information about the cause, and may mean the plan needs adjusting rather than repeating.

Yes. Review checks whether the benefit is holding, whether the dose or intensity is still needed, and whether anything can safely be reduced or stopped.

The clinician or service that treated you should have given you a contact route and an expected response time. For the urgent symptoms listed above, contact emergency services instead of waiting for a reply.

No. The current approved indication is acquired, generalised hypoactive sexual desire disorder in premenopausal women. Use outside that indication is not covered by the approval.

No. The approved product is a subcutaneous injection. A nasal or compounded preparation differs in formulation, absorption, supporting evidence and regulatory oversight, and should not be presented as equivalent.

The label describes a temporary increase in blood pressure with a reduction in heart rate, contraindication in uncontrolled hypertension or known cardiovascular disease, commonly severe nausea, and the possibility of persistent focal skin darkening.

A product supplied without a prescription has not been checked against your indication, cardiovascular status or other medicines, and its contents are not verified. This site does not link to, endorse or assist with any such supply.

No. This page explains what the approved label states. It does not prescribe, supply, recommend or provide a protocol, and it is not a route to obtaining the medicine.

No. It opens a conversation with an external licensed provider. An appointment exists only once that provider confirms it with you directly.

No. This site publishes information and does not operate a clinical record. It does not ask for symptoms, results or identifying health details.

You can ask a general information question without identifying yourself. Anything that requires clinical assessment will need identification by the provider carrying it out.

Contact emergency services or attend an emergency department. Contact links on this site are not monitored as an emergency channel and may not be seen quickly.

This guide is published in English and Arabic. Language availability at the external provider is a question for them directly.

Not by itself. People can want different amounts of sexual activity, and there is no target frequency both partners must meet. Discuss comfort and preferences without pressure. If a change is persistent, distressing or accompanied by pain, ask a clinician about the medical and relationship context rather than choosing a treatment from that difference alone.

Ask the provider before booking whether an interpreter familiar with medical terms can be arranged, in your preferred language, and whether there is a charge. A partner may not know the terminology or be someone you want to share every detail with. Confirm the interpreter's role and privacy arrangements; this website's English and Arabic pages do not guarantee language support at the appointment.